These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1967815)

  • 1. Glucose counterregulation in diabetes secondary to chronic pancreatitis.
    Larsen S; Hilsted J; Philipsen EK; Tronier B; Christensen NJ; Damkjaer Nielsen M; Worning H
    Metabolism; 1990 Feb; 39(2):138-43. PubMed ID: 1967815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus.
    White NH; Gingerich RL; Levandoski LA; Cryer PE; Santiago JV
    Diabetes; 1985 Sep; 34(9):870-5. PubMed ID: 2993084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function.
    Larsen S; Hilsted J; Tronier B; Worning H
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):357-64. PubMed ID: 2899369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired response of human pancreatic polypeptide to insulin-induced hypoglycemia in chronic pancreatitis without diabetes mellitus.
    Hanafusa T; Toyoshima H; Nonaka K; Tarui S
    Endocrinol Jpn; 1982 Oct; 29(5):509-15. PubMed ID: 6763560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
    Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
    Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
    Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
    Dejgaard A; Andersen P; Hvidberg A; Hilsted J
    Diabet Med; 1996 Nov; 13(11):983-9. PubMed ID: 8946158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
    Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic cholinergic antagonism does not enhance recovery from hypoglycemia in IDDM.
    Hvidberg A; Cryer PE
    Diabetes Care; 1995 Mar; 18(3):404-7. PubMed ID: 7555487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
    Towler DA; Havlin CE; Craft S; Cryer P
    Diabetes; 1993 Dec; 42(12):1791-8. PubMed ID: 8243825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal, metabolic, and circulatory responses to insulin-induced hypoglycemia in pregnant and nonpregnant women with insulin-dependent diabetes.
    Nisell H; Persson B; Hanson U; Lunell NO; Nylund L; Sarby B; Thronström S
    Am J Perinatol; 1994 May; 11(3):231-6. PubMed ID: 8048992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
    Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
    Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.